Anna Kopińska Grzegorz Helbig Andrzej Frankiewicz Iwona Grygoruk-Wiśniowska Sławomira Kyrcz-Krzemień
10.5114/wo.2012.29287
Contemp Oncol (Pozn)
2012;16(3):215-7.
allogeneic hematopoietic stem cell transplantation post-transplant lymphoproliferative disorder pure red cell aplasia rituximab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/23788882/
Case Reports
PMC3687412
23788882
Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation
2012